Table II.
Experimental groups, treatment summary and efficacy.
| Treatment description | Mice per group | Thermal dose? | Days to 3× | SD | Treatment ratio (versus no treatment) | |
|---|---|---|---|---|---|---|
| mNP + CDDP + AMF | CDDP 1 h before AMF exposure. mNP injected immediately before activation. Treated to CEM60 at centre of tumour | 7 | Yes | 36 | 2.4 | 2.6 |
| mNP + AMF | mNP injected immediately before activation. Treated to CEM60 at centre of tumour | 6 | Yes | 21 | 4.5 | 1.5 |
| CDDP alone | CDDP given with no additional treatment/treatment controls | 4 | No | 25 | 7.1 | 1.8 |
| CDDP + AMF | CDDP 1 h before AMF exposure. PBS injected at the same volume as prescribed mNP for other groups. Thermal probes inserted and exposed to AMF for 30 min | 4 | No | 25 | 6.3 | 1.8 |
| CDDP + mNP | CDDP 1 h before mNP injection. Animal under anesthesia with body temperature maintained for 30 min after mNP injection | 6 | No | 27 | 7.0 | 2.0 |
| AMF | PBS injected at the same volume as prescribed mNP for other groups. Thermal probes inserted and exposed to AMF for 30 min | 5 | No | 14 | 4.0 | 1.0 |
| No treatment | No treatments/treatment controls | 6 | No | 14 | 4.3 | 1.0 |